Published in Am J Gastroenterol on May 11, 2010
Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol (2014) 0.92
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev (2010) 0.92
Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer (2014) 0.83
Colorectal cancer screening in patients at moderately increased risk due to family history. World J Gastrointest Oncol (2012) 0.80
Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information. Med Decis Making (2012) 0.79
Familial colorectal cancer: a review. World J Gastroenterol (2014) 0.77
The impact of stratifying by family history in colorectal cancer screening programs. Int J Cancer (2015) 0.75
Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence. Cancer (2016) 0.75
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst (2003) 11.27
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ (2008) 4.77
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet (2003) 4.20
A model for a smallpox-vaccination policy. N Engl J Med (2002) 3.79
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer (2004) 2.89
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst (2009) 2.35
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ (2012) 2.05
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2011) 1.85
Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam. J Natl Cancer Inst (2010) 1.83
National Polyp Study data: evidence for regression of adenomas. Int J Cancer (2004) 1.83
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ (2009) 1.81
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making (2011) 1.71
Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol (2011) 1.66
The MISCAN-Fadia continuous tumor growth model for breast cancer. J Natl Cancer Inst Monogr (2006) 1.47
Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer (2006) 1.45
Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts. Value Health (2011) 1.44
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial. Int J Cancer (2002) 1.41
A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials. Cancer (2009) 1.37
Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer (2007) 1.37
Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys (2008) 1.36
Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst (2011) 1.33
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med (2014) 1.32
Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer (2007) 1.30
Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst (2002) 1.24
Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med (2010) 1.24
Developing and interpreting models to improve diagnostics in developing countries. Nature (2006) 1.18
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. J Natl Cancer Inst Monogr (2006) 1.15
Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut (2012) 1.14
Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer (2006) 1.13
Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine (2010) 1.11
Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol (2010) 1.11
Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol (2010) 1.10
Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature (2006) 1.09
Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation. Int J Cancer (2004) 1.08
Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol (2011) 1.07
Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study. Gastroenterology (2013) 1.01
Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut (2013) 1.00
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening. Gut (2012) 0.96
Breast cancer screening: evidence for false reassurance? Int J Cancer (2008) 0.96
Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines. Int J Cancer (2005) 0.94
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? Cancer (2011) 0.93
Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies. Int J Cancer (2007) 0.93
Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening. Histopathology (2011) 0.93
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol (2013) 0.92
Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control (2010) 0.92
Process performance of cervical screening programmes in Europe. Eur J Cancer (2009) 0.92
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrol (2013) 0.90
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. Value Health (2008) 0.89
Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer (2011) 0.89
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting. Oncologist (2013) 0.85
Post-treatment CIN: randomised clinical trial using hrHPV testing for prediction of residual/recurrent disease. Int J Cancer (2009) 0.85
Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness? Eur J Cancer (2011) 0.85
Parental decisional strategies regarding HPV vaccination before media debates: a focus group study. J Health Commun (2013) 0.84
Anxiety and borderline PAP smear results. Eur J Cancer (2010) 0.84
Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results. Patient Educ Couns (2011) 0.83
No increased risk for cervical cancer after a broader definition of a negative Pap smear. Int J Cancer (2008) 0.83
Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. Int J Cancer (2011) 0.82
Increasing girls' knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study. BMC Public Health (2013) 0.81
Does lowering the screening age for cervical cancer in The Netherlands make sense? Int J Cancer (2008) 0.80
Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment. BMC Public Health (2014) 0.79
Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information. Med Decis Making (2012) 0.79
Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. Radiology (2011) 0.78
How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age? Int J Cancer (2013) 0.78
United States Preventive Services Task Force recommendations: age to end screening misunderstood. Dis Colon Rectum (2010) 0.78
Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study. Cancer Causes Control (2014) 0.77
Simulation of colorectal cancer screening: what we do and do not know and does it matter. Best Pract Res Clin Gastroenterol (2010) 0.77
Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis. Cancer Causes Control (2012) 0.77
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening. Med Care (2015) 0.76
Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytology. Acta Cytol (2011) 0.76
Women show mixed intentions regarding the uptake of HPV vaccinations in pre-adolescents: a questionnaire study. Eur J Cancer (2008) 0.76
Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II. BMC Public Health (2006) 0.75
Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project. BMC Cancer (2011) 0.75
Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costs. J Clin Epidemiol (2002) 0.75